Cargando…
Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis
BACKGROUND: Antithrombotic (anticoagulant or antiplatelet) therapy is withheld from some patients with cerebral cavernous malformations, because of uncertainty around the safety of these drugs in such patients. We aimed to establish whether antithrombotic therapy is associated with an increased risk...
Autores principales: | Zuurbier, Susanna M, Hickman, Charlotte R, Tolias, Christos S, Rinkel, Leon A, Leyrer, Rebecca, Flemming, Kelly D, Bervini, David, Lanzino, Giuseppe, Wityk, Robert J, Schneble, Hans-Martin, Sure, Ulrich, Al-Shahi Salman, Rustam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Pub. Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744367/ https://www.ncbi.nlm.nih.gov/pubmed/31401075 http://dx.doi.org/10.1016/S1474-4422(19)30231-5 |
Ejemplares similares
-
Association Between Beta-Blocker or Statin Drug Use and the Risk of Hemorrhage From Cerebral Cavernous Malformations
por: Zuurbier, Susanna M., et al.
Publicado: (2022) -
Higher risk of intracranial aneurysms and subarachnoid haemorrhage in siblings of families with intracranial aneurysms
por: Zuurbier, CCM, et al.
Publicado: (2019) -
Clinical course of untreated cerebral cavernous malformations: individual patient data meta-analysis
por: Horne, Margaret, et al.
Publicado: (2013) -
De novo hemorrhagic sporadic cavernous malformation appearance after COVID-19 respiratory infection: illustrative case
por: Holmes, Carmen R., et al.
Publicado: (2021) -
Microsurgical resection of an enlarging lateral pontomedullary cavernous malformation
por: Cohen-Cohen, Salomon, et al.
Publicado: (2019)